Research

Energy balance

Most trials suffered from publication bias.

Practitioners should be aware of potential biases in the published literature on anti-obesity drugs.

StrongSupportsmedium confidence
Most trials suffered from publication bias.
Eleni A. Karavia et al. · Nutrients · 2023

Why this rating

Based on systematic review of phase III/IV clinical trials.

Source

Medicines for Obesity: Appraisal of Clinical Studies with Grading of Recommendations, Assessment, Development, and Evaluation Tool

Eleni A. Karavia et al. · Nutrients · 2023

DOI 10.3390/nu15030606

systematic_reviewCited 5×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →